Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Neuraxis, Inc. (NRXS : AMEX)

• Company Description    NeurAxis, Inc. is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. NeurAxis, Inc. is based in CARMEL, Ind. Number of Employees: 24

• Price / Volume Information    Yesterday's Closing Price: $7.40 Daily Weekly Monthly 20 Day Moving Average: 148,845 shares Shares Outstanding: 12.56 (millions) Market Capitalization: $92.93 (millions) Beta: 1.38 52 Week High: $9.33 52 Week Low: $2.21 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -4.52% -3.51% 12 Week 17.83% 14.96% Year To Date 63.00% 49.53%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 11611 N. Meridian Street Suite 330 - Carmel,IN 46032 USA ph: 812-689-0791 fax: - ir@neuraxis.com https://neuraxis.com

• General Corporate Information    Officers Brian Carrico - President; Chief Executive Officer and Director Bradley Mitch Watkins - Director and Chairman of the Board Timothy Henrichs - Chief Financial Officer Adrian Miranda - Senior Vice President of Science and Technology Beth Keyser - Director Peer Information Neuraxis, Inc. (HLIS) Neuraxis, Inc. (AZTA) Neuraxis, Inc. (APYI) Neuraxis, Inc. (RNVA) Neuraxis, Inc. (HMSY) Neuraxis, Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 64134X201 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/09/26 Share - Related Items Shares Outstanding: 12.56 Most Recent Split Date: (:1) Beta: 1.38 Market Capitalization: $92.93 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.18 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.76 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/09/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 13.72 Price/Cash Flow: - Price / Sales: 17.48 EPS Growth vs. Year Ago Period: 13.64% vs. Previous Quarter: -5.56% Sales Growth vs. Year Ago Period: 115.77% vs. Previous Quarter: 19.96% ROE 09/30/26 - - 06/30/26 - -169.22 03/31/26 - -185.91 ROA 09/30/26 - - 06/30/26 - -99.33 03/31/26 - -103.99 Current Ratio 09/30/26 - - 06/30/26 - 3.04 03/31/26 - 2.89 Quick Ratio 09/30/26 - - 06/30/26 - 2.95 03/31/26 - 2.81 Operating Margin 09/30/26 - - 06/30/26 - -144.45 03/31/26 - -170.12 Net Margin 09/30/26 - - 06/30/26 - -144.45 03/31/26 - -170.12 Pre-Tax Margin 09/30/26 - - 06/30/26 - -144.45 03/31/26 - -170.12 Book Value 09/30/26 - - 06/30/26 - 0.54 03/31/26 - 0.50 Inventory Turnover 09/30/26 - - 06/30/26 - 3.48 03/31/26 - 3.48 Debt-to-Equity 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00 Debt-to-Capital 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00

Powered by Zacks Investment Research ©